Collectively, these results reveal that the robust killing of NSCLC cell lines is mediated by inhibition of the pro-proliferative EGFR pathway combined with DR4/5-triggered caspase-induced apoptosis. Here, EGFR is linked to non-small cell lung carcinoma.